KENT WILLIS: Open Payments
NPI 1114306131 · PLEASANT GROVE, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$696 in 37 payments from 16 companies in 2025. Trend: 2023 $946 · 2024 $814 · 2025 $696
Food & beverage: $636Education: $60
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $267 |
| Astellas Pharma US Inc | 1 | $60 |
| Phathom Pharmaceuticals, Inc. | 4 | $59 |
| GlaxoSmithKline, LLC. | 3 | $44 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $34 |
| Aimmune Therapeutics, Inc. | 2 | $34 |
| Edwards Lifesciences Corporation | 1 | $29 |
| Neuronetics, Inc. | 1 | $22 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $22 |
| Viatris Specialty LLC | 1 | $20 |
Products named: VRAYLAR, UBRELVY, VOQUEZNA, QULIPTA, SHINGRIX, Kerendia, ZENPEP, SAPIEN 3 Ultra RESILIA.
Industry payments across UT — which companies pay providers there.
